Synthélabo is a French pharmaceutical company known for its research and development in the field of medicine. It specializes in creating innovative treatments and therapies, focusing on areas such as neurology, oncology, and cardiology. The company aims to improve patient outcomes through advanced scientific methods and collaboration with healthcare professionals. Founded in the late 20th century, Synthélabo has grown through strategic partnerships and acquisitions, including its merger with Sanofi in 2004. This merger expanded its global reach and enhanced its capabilities in drug development. Synthélabo continues to contribute to the healthcare industry by delivering effective solutions for various medical conditions.